MRNS Message Board Post 10890348 | Marinus Pharmaceuticals...
home / stock / mrns / mrns message board
(investorshangout)
Posted on: Oct/31/2022 12:25:50
Source: investorshangout
https://investorshangout.com/post/view?id=6491622
whytestocks: $MRNS News Article - Marinus Pharmaceuticals Announces $32.5 Million Revenue Interest Financing Agre
News, Short Squeeze, Breakout and More Instantly...
Marinus Pharmaceuticals Inc. Company Name:
MRNS Stock Symbol:
Market:
Marinus Pharmaceuticals Inc. Website:
- MRNS - Marinus Pharmaceuticals Announces Key Business Updates for Tuberous Sclerosis Complex Program
Enrollment complete in Phase 3 TrustTSC trial with topline data anticipated in the first half of Q4 2024 USPTO grants additional method of use patent for ganaxolone in TSC Marinus Pharmaceuticals , Inc. (Nasdaq:MRNS), a pharmaceutical company dedicated to the development of ...
-
Apartment Investment and Management Company (AIV) is expected to report for Q1 2024 Shopify Inc. Class A Subordinate (SHOP) is expected to report $0.08 for Q1 2024 Beyond Meat Inc. (BYND) is expected to report $-0.68 for Q1 2024 Instructure Holdings Inc. (INST) is expected to report $...
-
ZTALMY ® (ganaxolone) Q1 2024 net product revenue of $7.5 million representing strong growth of 125% versus Q1 2023 Increased full year 2024 projected U.S. ZTALMY net product revenues to between $33 and $35 million Enrollment to be completed mid-May in the Phase 3 TrustTSC trial ...